ResMed Inc.
Moat Score — ResMed Inc.
Total Moat Score
18 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 4 / 5 | ResMed holds substantial patents around its CPAP device and mask technology, FDA clearances, and a trusted clinical brand that was further strengthened when rival Philips Respironics suffered a major product recall. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 3 / 5 | Global manufacturing scale gives ResMed cost advantages over smaller regional rivals, though it competes on quality and reliability rather than being the lowest-cost option, ceding price-sensitive segments to Asian manufacturers. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 3 / 5 | ResMed has been able to command premium pricing versus lower-cost entrants and gained share after Philips' recall, though reimbursement dynamics with insurers ultimately cap how much pricing power it can exercise. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | The AirView/myAir connected-care ecosystem creates some data-driven value as more patients and clinicians use it, but this is a modest effect compared to true multi-sided network businesses. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 4 / 5 | Patients must continually repurchase masks and consumables matched to their specific device, and clinicians and insurers rely on ResMed's compliance-data platforms, creating durable, recurring lock-in across the installed base. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 3 / 5 | The CPAP market is effectively a duopoly between ResMed and Philips (with smaller niche players), and FDA regulatory requirements plus manufacturing scale needed to compete on quality limit the number of credible global entrants. |